Immunomedics (IMMU) Misses Q1 EPS by 86c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
General and administrative: 691.58K
Today's EPS Names:
PFBX, GOVB, VABK, More
Financial Fact:
General and administrative: 691.58K
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.97), $0.86 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $690.49 million, versus $741.81 million reported last year.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- Exponent, Inc. (EXPO) Tops Q3 EPS by 4c; offers outlook
- Alignment Healthcare, Inc. (ALHC) Reports In-Line Q3 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
